• Featured Product
  • KD/KO Validated

ADRA1A-Specific Polyclonal antibody

ADRA1A-Specific Polyclonal Antibody for FC, WB,ELISA

Host / Isotype

Rabbit / IgG


human, mouse, rat





Cat no : 19777-1-AP


ADRA1A, ADRA1C, ADRA1L1, Alpha 1A adrenergic receptor, Alpha 1A adrenoceptor, Alpha 1A adrenoreceptor, Alpha 1C adrenergic receptor, Alpha adrenergic receptor 1c, ALPHA1AAR

Tested Applications

Positive WB detected inmouse heart tissue, HeLa cells, mouse brain tissue
Positive FC detected inHepG2 cells

Recommended dilution

Western Blot (WB)WB : 1:500-1:2000
Sample-dependent, check data in validation data gallery

Product Information

19777-1-AP targets ADRA1A-Specific in WB, IHC, IF, FC,ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Peptide
Full Name adrenergic, alpha-1A-, receptor
Calculated molecular weight 51 kDa
Observed molecular weight 52 kDa
GenBank accession numberNM_000680
Gene symbol ADRA1A
Gene ID (NCBI) 148
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

ADRA1A, also named as ADRA1C, belongs to the G-protein coupled receptor 1 family. ADRA1A mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. The antibody is specific to ADRA1A.


Product Specific Protocols
WB protocol for ADRA1A-Specific antibody 19777-1-APDownload protocol
FC protocol for ADRA1A-Specific antibody 19777-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Vascul Pharmacol

The ERK1/2 pathway participates in the upregulation of the expression of mesenteric artery α1 receptors by intravenous tail injections of mmLDL in mice.

Authors - Jun-Jie Wang

Pharmaceuticals (Basel)

Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer's Disease.

Authors - Miles Frost